Vor Bio to Participate in the Stifel 2024 Healthcare Conference

VOR 11.12.2024

Full Press ReleaseSEC FilingsOur VOR Tweets

About Gravity Analytica

Recent News

  • 01.08.2025 - Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors
  • 12.30.2024 - A Look back on 2024
  • 12.27.2024 - Vor Bio Announces $55.6 Million Private Placement

Recent Filings

  • 01.21.2025 - S-3 Registration statement under Securities Act of 1933
  • 01.08.2025 - 3 Initial statement of beneficial ownership of securities
  • 01.08.2025 - 4 Statement of changes in beneficial ownership of securities

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host 1x1 investor meetings at the Stifel 2024 Healthcare Conference.

Stifel 2024 Healthcare ConferenceFireside Chat: Monday, November 18, 2024 at 2:25 pm ETLocation: New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section ofwww.vorbio.com.

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit:www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer+1 857-242-6076sspencer@vorbio.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com